NOD1 and cardiac hypertrophy: However, recent studies have revealed that MAVS acts nucleotide-binding oligomeric structural domain-containing protein 1/receptor-interacting protein 2 (NOD1/RIP2) downstream to promote cardiac hypertrophy in response to transecting pressure overload induced by aortic constriction (TAC).